Prolor Biotech (PBTH +4.9%) reports positive pre-clinical results from an animal study for its...

|By:, SA News Editor

Prolor Biotech (PBTH +4.9%) reports positive pre-clinical results from an animal study for its obesity and Type II diabetes drug candidate MOD-6030. When administered once a week over 30 days, PBTH says the treatment produced an average weight loss of 28% and a 19% reduction in blood glucose levels.